FDA Approved: TEPMETKO — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Tepmetko (tepotinib hydrochloride) submitted by EMD Serono, Inc., to update/expand the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tepmetko (tepotinib)

Snippet

SUPPL AP for TEPMETKO (TEPOTINIB HYDROCHLORIDE)